TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study.

Matthew J Ellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.